Revenues, Recognition and Allowances (Tables)

12 Months Ended

Dec. 31, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net Sales (in thousands) for the two years ended December 31, 2020 and 2019 were as follows:

	Years ended December 31,
	2020		2019
Company product sales	$	43,604	$	64,291
Contract manufacturing sales	1,157		1,362
Research and development services and other income	548		243
Revenue, net	$	45,309	$	65,896

Disaggregated information for the Company product sales revenue has been recognized in the accompanying Consolidated Statements of Operations, and is presented below according to contract type (in thousands):

	Years ended December 31,
Company Product Sales	2020		2019
Topical	$	32,750	$	46,150
Injectables	10,854		18,141
Total	$	43,604	$	64,291

Schedule Of Annual Activity Allowance For Customer Deductions Disclosure

The Company's adjustments for the deductions to gross product sales for the years ended December 31, 2020 and 2019 are as follows (in thousands):

	Years ended December 31,
	2020		2019
Gross product sales	$	140,616	$	156,301
Reduction to gross product sales:
Chargebacks and billbacks	73,656		60,008
Wholesaler fees for service	5,745		9,000
Sales discounts and other allowances	17,611		23,002
Total reduction to gross product sales	$	97,012	$	92,010
Total product sales, net	$	43,604	$	64,291